Source: BioPortfolio

Igenica: Igenica Biotherapeutics Inc Pharmaceuticals Healthcare Deals and Alliances Profile Prices from USD $250

SummaryIgenica Biotherapeutics Inc Igenica focuses on the development of on the discovery and development of antibodies and antibodydrug conjugates ADCs for the treatment of cancer. The company's portfolio of product candidates includes IGN523 a humanized ...

Read full article »
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Robert Schreiber's photo - Co-Founder of Igenica

Co-Founder

Robert Schreiber

CEO Approval Rating

78/100

Read more